Board Meeting Announcement for Bliss GVS Pharma Ltd - May 12, 2025

Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve a) The Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025 along with the Statement of Assets and Liabilities Cash Flow Statement and take note of the Audit Report with modified opinion if any thereon. b) The Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31 2025 and c) Recommend the Final Dividend if any for the financial year ended March 31 2025 Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider and approve Update on board meeting- To consider and approve the proposal for issuance of Sweat Equity Shares. Enclosed herewith please find attached intimation in this regard (As per BSE Announcement Dated on 07/05/2025)